Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Escitalopram has been claimed to have the highest selectivity for the human serotonin
transporter relative to the noradrenaline or dopamine transporters. This might be associated
with greater clinical efficacy. Most adverse events reported by escitalopram-treated patients
are mild and transient.
In this study, we compare escitalopram with placebo in the treatment of PE.